H1/IC31: Phase II data

A double-blind, placebo-controlled, African Phase II trial in 48 antiretroviral-naïve HIV-infected adults ages 18-55 with CD4+ lymphocyte counts of >350/mm 3 showed that intramuscular H1/IC31 given on...